Nelson Advisors partner Lloyd Price has been interviewed by Healthcare Business International for their 'Sigma Healthcare drops out of talks to acquire Boots' story focused on the strategic M&A and IPO options available to Boots and their PE owners Sycamore Partners.

Nelson Advisors partner Lloyd Price was interviewed by Healthcare Business International for their 'What does the £900M NHS AI framework mean for UK healthcare?' story.

Healthcare Business International interviewed Nelson Advisors partner Lloyd Price discussing Healthbridge's acquisition of AI scribe Nora. “The acquisition highlights a broader shift in the industry, as companies are leaning more toward acquisitions instead of building everything in-house,” Lloyd Price, partner at M&A advisory firm Nelson Advisors told HBI.

Nelson Advisors Partner Lloyd Price has been interviewed by Healthcare Business International regarding hims & hers acquisition of Australian Digital Health platform Eucalyptus Lloyd Price, partner at M&A advisory firm Nelson Advisors, a consultancy that focuses exclusively on the healthcare technology (healthtech) and medical technology (medtech) sectors, tells HBI the acquisition serves both defensive and offensive purposes. “Strategically, it hedges against rising US regul

The outpatient sector in Europe, long fragmented into millions of providers, is the new frontier for consolidation. And no market is...